EcoDrugPlus

Kinase Insert Domain Receptor

Ensembl ID : ENSCHOG00000012579
Gene Symbol: KDR
1 Cross references
199 Possible Orthologues:

Kinesin Family Member 11

Ensembl ID : ENSCHOG00000006230
Gene Symbol: KIF11
1 Cross references
203 Possible Orthologues:

Leukotriene A4 Hydrolase

Ensembl ID : ENSCHOG00000010705
Gene Symbol: LTA4H
1 Cross references
207 Possible Orthologues:

Lysine Demethylase 1a

Ensembl ID : ENSCHOG00000012040
Gene Symbol: KDM1A
1 Cross references
214 Possible Orthologues:

Matrix Metallopeptidase 1

Ensembl ID : ENSCHOG00000013121
Gene Symbol: MMP1
1 Cross references
348 Possible Orthologues:

Matrix Metallopeptidase 12

Ensembl ID : ENSCHOG00000008413
Gene Symbol: MMP12
1 Cross references
560 Possible Orthologues:

Matrix Metallopeptidase 13

Ensembl ID : ENSCHOG00000009858
Gene Symbol: MMP13
1 Cross references
202 Possible Orthologues:

Matrix Metallopeptidase 7

Ensembl ID : ENSCHOG00000002096
Gene Symbol: MMP7
1 Cross references
163 Possible Orthologues:

Matrix Metallopeptidase 8

Ensembl ID : ENSCHOG00000007918
Gene Symbol: MMP8
1 Cross references
111 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSCHOG00000012750
Gene Symbol: MTOR
1 Cross references
224 Possible Orthologues:

Melanocortin 4 Receptor

Ensembl ID : ENSCHOG00000006674
Gene Symbol: MC4R
1 Cross references
229 Possible Orthologues:

Melatonin Receptor 1a

Ensembl ID : ENSCHOG00000009315
Gene Symbol: MTNR1A
1 Cross references
216 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).